Status | Study |
Completed |
Study Name: Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis Condition: Pediatric Ulcerative Colitis Date: 2012-04-24 Interventions: Drug: TA-650 TA-650 will be intravenously infused at 5 mg/kg as an induction regimen at Weeks 0, 2, 6. F |
Completed |
Study Name: Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis Condition: Mild to Moderate Ulcerative Colitis Date: 2010-09-12 Interventions: Drug: Mesalamine Dosing: The current standard of care for |
Withdrawn |
Study Name: Lactobacillus GG in Pediatric Ulcerative Colitis (UC) Condition: Ulcerative Colitis Date: 2009-04-27 Interventions: Biological: Lactobacillus GG 1 capsule taken twice daily for a minimum of 28 days to a maximum of 35 day |
Terminated |
Study Name: Metabolic Response to Infliximab in Pediatric Ulcerative Colitis Condition: Ulcerative Colitis Protein Metabolism Energy Expenditure Date: 2007-12-21 Interventions: Other: Stable amino acid isotopes Stable amino acid isotopes given per IV, dose based on weight and give |